Trial intelligence / Profile preview

Micronized progesterone pharmacokinetics and tolerability study in healthy postmenopausal women

ChiCTR1800019081Phase 4Recruiting

Sponsor
Peking Union Medical College Hospital
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of progesterone (4 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Pharmacokinetic parameters. Started Oct 2018; status: recruiting.

02

Drugs

progesterone

Beyond the preview

Go deeper on ChiCTR1800019081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800019081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call